Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
José Baselga(Harvard University), A. Eckardt(Merck KGaA, Darmstadt (Germany)), José Trigo(Heidelberg University), Nadia Amellal(Merck KGaA, Darmstadt (Germany)), Ricardo Hitt(Hospital Universitario Severo Ochoa), Jean Bourhis(University of Lausanne), A. Harstrick(Merck KGaA, Darmstadt (Germany)), H. Cortés-Funes(Centre Hospitalier René-Dubos), J. Tortochaux(Merck KGaA, Darmstadt (Germany)), Pere Gascón(Merck KGaA, Darmstadt (Germany))
Cited by 491
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
|New England Journal of Medicine|2008|3.7k
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k